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(12 pts). Group 2: FFRti.75 (44 pts). Results: In pts with reduced FFR (group 1) 
LAminr4.0 mm2 was obtained in 3 pts (25%). Moreover, LAminc4.0 mm’was present in 
16 pts (38%) despite of FFRa0.75 (group 2). The comparison of QCA, FFR and ICUS 
parameters between the two groups is shown in table. Conclusions: ICUS assessment of 
the minimal luminal cross-sectional area has only a limited value in determining the clini- 
cal importance of intermediate coronary lesion. Other factors, such as lesion length may 
also influence functional severity of intermediate coronary lesion. 
Ref.DacA L&A MLDacn D%XA FFR LAmintcus LLICUS 
Group1 3.02Y~O.54 18.3i5.8 1.5Mo.17 49.7f7.0 0.67fo.06 3.20M.45 19.5i7.14 
Group2 3.06iO.38 11.3zk3.9 1.48M.27 51.8f7.8 0.85fo.05 3.74il.01 11.2?5.13 
P= NS 0.018 NS NS 0.0027 0.042 0.0017 
1077-26 Pulse Transmisston Coefficient: A Novel Nonhyperemic 
Index for Physiologic Assessment of Procedural 
Success Following Percutaneous Coronary 
Interventions 
Dsyid&&, Stuart T. Higano. Marvin J. Slepian, Hylton I. Miller, Morton J. Kern, David 
R. Holmes, Jr., Amir Lerman, Mayo Clinic Foundation, Rochester, Minnesota, Saint Louis 
University, Saint Louis, Missouri. 
Background: Coronary lesions may impair the transmission of pressure waves across a 
stenosis, potentially acting as a low-pass filter. The pulse transmission coefficient (PTC) 
is a novel non-hyperemic parameter that calculates the transmission of high frequency 
components of the pressure signal through a stenosis. Thus, it may reflect the severity of 
the coronary artery stenosis, This study was designed to study the change of PTC as 
compared to fractional flow reserve (FFR), following percutaneous coronary intervention 
(PCI). 
Methods: Pressure signals were obtained by pressure guidewire in 27 lesions (27 pts.) 
pre and post PCI, and were analyzed with a new algorithm (Florence Medical Ltd.) that 
identifies the high frequency component in the pressure signal. The PTC was calculated 
as the ratio between distal and proximal high frequency components of the pressure 
waveform across the lesion. FFR measurements were assessed with intracoronary ade- 
nosine. 
Results: There was a significant increase in PTC following PCI (0.12iO.03 at baseline to 
0.95M.01 post PCI; p<O.OOl; Figure). Comparable changes were observed for FFR 
(0.57+0.03 at baseline to 0.91M.01 post PCI; p<O.OOl). 
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Conclusions: PTC is a novel non-hyperemic parameter for physiologic assessment of 
coronary artery stenoses. Similarly to FFR. PTC is significantly increased following PCI. 
Thus, It may serve as an adjunct index for the functional assessment of procedural suc- 
cess following PCI, especially in patients with impaired maximal hyperemia. 
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1076-l 1 Lack of Benefit From Routine Functional Testing 
Among Patients Undergoing Coronary Stenting: 
Insights From the ADORE Trial 
Koon_Hou, Radha Pun, Mark J. Eisenberg, National Heart Centre, Singapore, 
Singapore, Jewish General Hospital, Montreal, Quebec, Canada. 
Background: With increasing number of patients undergoing coronary stenting (CS), the 
role of routine functional testing (FT) is unclear. Our study aims to determine the value of 
this strategy. Mathods: The ADORE Trial randomly assigned 328 patients with success- 
ful coronary angioplasty In 9 countries to selective (clinically ddven) or routine Ff at 6 
weeks, 8 and 9 months after the procedure. Patients were followed-up for adverse clini- 
cal events. The use of invasive and revascluarization procedures were left to the discre- 
tion of the attending physicians. Exercise treadmill testing was performed on all patients 
at 9 months. Resufts: Of 278 (85%) of patients undergoing CS, 148 and 130 of them 
were assigned to the selective and routine groups, respectively. Baseline characteristics 
were similar. Overall, the mean age was 57 years, and 85% of them were male, about a 
sixth had diabetes or prior infarction, and a third had prior angioplasty. Almost 90% of 
patients had single-vessel disease and ~50% had 92/C lesion characteristics. The distri- 
bution of the vessel and number of lesions treated were also similar between the 2 
groups. After a follow-up period of 9 months, the occurrences of adverse events were as 
follows: 
Event Selective Routine 
Death (%) 1 2 
Myocardial Infarction (MI) (%) 2 2 
Unstable angina (UA) (%) 8 10 
Repeat angiography (%) 12 14 
Revascularization (%) 8 12 
Composite (death/UAIMI) (%) 7 6 
Exercise capacity was marginally lower in the selective group (9.4 vs 10.2 METS; 
P=O.O84). Conclusion: Routine FT did not prevent adverse clinical events among 
patients undergoing coronary stenting. 
1078-12 Smoking and Restenosis After Coronary Artery 
Stenting: The Artifact of Smoker’s Paradox 
Julinda, Adnan Kastrati. Josef Dirschinger, Jfirgen Pache, Helmut SchShlen. 
Heidrun Holle, Franz Dotzer, Franz-Josef Neumann, Albert Schomig, Deutsches 
Herzzentrum, Munich, Germany, 1. Med. Klinik rechts der tsar, Munich, Germany 
Background: Cigarette smoking is a strong risk factor for heart disease. Some previous 
studies showed a lower incidence of adverse events and restenosis after percutaneous 
coronary interventions (PCI) in smokers which has since been called the ‘smoker’s para- 
dox’. We investigated the influence of smoking on restenosis after stenting. 
Methods: A consecutive series of 6911 patients who underwent coronary artery stenting 
was analyzed. The follow-up protocol included 8-month angiography (performed in 80% 
of the patients) and a contact 12 months after the procedure. Primary endpoint of the 
study was angiographic restenosis defined as a 2 50% diameter stenosis at follow-up. 
Other endpoints were the combined rate of death or myocardial infarction and the need 
for reinterventions at 1 year. 
Resufts: As shown in the table, the risk profile of the smokers is significantly different 
from that of nonsmokers. Apparently, smokers have a lower risk for restenosis. However, 
the risk reduction disappears after adjustment for baseline characteristics: adjusted odds 
ratio, 0.94 [95% Cl, 0.81-1.091. More importantly, smokers showed a significantly 
increased risk of death or myocardial infarction (adjusted hazard ratio, 1.29 [95% Cl, 
1.03.1.81]). 
Conchtalons: The apparent relation between smoking and a lower restenosis rate after 
PCI is the consequence of more favorable baseline characteristics. Smoking itself has an 
unfavorable influence on the outcome after stenting by increasing the risk of the most 
dreadful events. 
Unlvariate analysis 
Age. yrs 
Women, % 
Diabetes, % 
Multivessel disease, % 
Vessel size, mm 
Angiographic restenosis. % 
Reinterventions, % 
Death or MI, % 
Smokers (n=1848) Nonsmokers (n=5083) 
59tll 67*10 <O.OOl 
18 27 <O.OOl 
15 22 <O.OOl 
67 75 <O.OOl 
3.08*0.51 3.00*0.54 <O.OOl 
28 31 0.04 
17 19 0.13 
8.4 6.9 0.54 
1078-13 Is Direct Stenting an Effective Therapy for Long-Term 
Outcome? Results of the Randomized Bet Study 
&drer Carrie, Khalife Khalife, Bernard Citron, Kari Isaaz, Martial Hamon, Jean M Juliard, 
Elyes El Mokhtar, Jean P Rinaldi, Joelle Fourcade, Remi Sabatier, for the Bet SrUdy 
Group, Toulouse, France. 
Background : The BET (Benefit Evaluation of Direct Coronary Stenting) study is multi- 
venter randomized trial comparing direct (without balloon predilatation) versus conven- 
tional stent implantation (Tenax. Biotronik inc.) to evaluate immediate and long-term 
outomes. 
We have demonstrated that Direct Stenting (DS=) is feasiblesafe, with reduction of pro- 
cedural cost and similar in-hospital clinical outcome. Long-term outcome is unknown and 
no comparison exists with conventional stenting (DS-). 
Methods : 328 randomized patients had a mean clinical follow-up of 16.4 + 4.8 months 
(3.1 - 23.7) which allows to evaluate ma]or adverse cardiac events (MACE) and target 
lesion revascularization (TLR) rates. 
DS (-) DS (+) 
n=181 n=187 
MACE TLR MACE TLR 
3 Months 1.9% 1.2% 1.2 % 0.8 % 
8 Months 5.1 % 3.2 % ns 5.4 % 3.7 % 
12 Months 9.1 % 5.2 % 10.8 % 7% 
More than 18 months 11.3% 5.2 % 18.2 % 7% 
